In this online, self-learning activity: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a demyelinating, autoimmune condition affecting the central nervous system. MOGAD is characterized by the presence of autoantibodies directed against the MOG protein located on the surface of myelin sheaths surrounding nerve fibers in the CNS. The disease course may be monophasic or relapsing, and a progressive course is extremely rare, making the mortality rate fairly low (2.1%) compared to other neuroinflammatory diseases. It is a relatively new addition to the category of demyelinating diseases, and approximately 10,000 cases of MOGAD are estimated within the U.S.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
52 of 52 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Cardiovascular Disease
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Hematology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Radiology
- Pediatric Transplant Hepatology
- Pulmonary Disease
- Rheumatology
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedMar 20, 2025
-
Last day to claim creditMar 21, 2027 5 months left
-
touchIME, USF Health Recognizing MOGAD: Defining a distinct demyelinating disease
-
American Society of Neuroradiology Pediatric Demyelinating Disease: Emerging Patterns from Multiple Sclerosis to Anti-Myelin Oligodendrocyte Glycoprotein-Associated Encephalomyelitis
-
Physicians’ Education Resource Proposed Pathways Underlying MOGAD
-
ScientiaCME The gMG care continuum: timely recognition, steroid-sparing strategy, and targeted therapy integration in generalized myasthenia gravis
-
ScientiaCME Taking aim at IgA nephropathy (IgAN): present gaps and evolving management strategies
-
ScientiaCME Alagille syndrome: best practices in its recognition and a review of present and novel approaches to management
